Contact

ALS Worldwide welcomes any questions or comments you might have.  We provide free, personalized and confidential support services to anyone in the ALS community—whether you are a patient or a loved one, friend, health care professional or caregiver of someone diagnosed.

Get help now! Fill out the Online Profile Form or if you would prefer to talk with someone by email or phone first, please contact us at [email protected] or 1-608-663-0920.

For all other inquiries, please use the email form to the right and we will respond promptly to your request.Thank you.

ALS Worldwide
5808 Dawley Drive
Fitchburg, WI 53711‑7209

ALS Worldwide
May 06, 2017

FDA Approval of Edaravone

On May 5, 2017, FDA authorization was granted to Mitsubishi Tanabe Pharma America, Inc. to manufacture and distribute this important medication. *View ALS Worldwide Press Release

May 03, 2017

ALS Worldwide Offers Personalized Support

ALS Worldwide holds personalized Skype and/or Facebook sessions with those fighting ALS and their loved ones.

April 26, 2017

Are You Facing High-Cost Treatment Options For ALS?

ALS Worldwide endorses drugs that we feel are both worth the cost and beneficial. The newest trial pharmaceuticals we endorse are Edaravone and Masitinib.

April 24, 2017

Are ALS And Schizophrenia Related Diseases?

Through a recently published study, researchers have found schizophrenia in relatives of ALS patients is caused by shared genetic factors that increase the risk of both conditions.

April 24, 2017

Are Animal Models Still Effective For Treating Human Diseases?

Scientists are reevaluating the use of animal studies for treating diseases like ALS.

April 17, 2017

Brilliant Find by Mayo Clinic Should Help Develop New Therapies For ALS

ALS doesn't have a cure, but a Mayo Clinic team found a protein that could lead to development of new therapies.